Dutch Hospital conducts a clinical trial of Erector Spinae Block for Thoracoscopic Surgery
St. Antonius Hospital is conducting the clinical trial Erector Spinae Block for Thoracoscopic Surgery.
This clinical trial compares the effects of the erector spinae plane block with levobupivacaine and 0,9% saline on postoperative pain intensity, and opioid consumptions following thoracoscopic pulmonary surgery.
It is planned to include 60 participants.
Actual study start date is October 21, 2020. The researchers expect to complete the study by June 1, 2021.
One primary outcome measure is Pain intensity (NRS) 4 hours after surgery, Pain level 4 hours after surgery.
Among the inclusion conditions appear:
- Patients scheduled for thoracoscopic pulmonary sleeve resection or lobectomy
- Age 18 years or older
- American Society of Anesthesiologists (ASA) health status class I-III
Among the criteria that do not allow participation, the following are indicated:
- Contraindication for regional analgesia (e.g. coagulopathy, infection at injection site)
- Contraindication for NSAIDs
- Chronic opioid use
- Pregnancy
The location of the study is as follows (further details can be found here https://ichgcp.net/clinical-trials-registry/NCT04751552) Nieuwegein, Netherlands.
The Sankt-Antonius-Hospital Eschweiler (SAH) in the center of the city of Eschweiler is with its 11 specialist clinics and 12 interdisciplinary competence centers the largest denominational hospital in the Aachen city region. The facility has been the academic teaching hospital of RWTH Aachen University since October 1st, 1977 and employs around 1,300 people. The St. Antonius Hospital has been a registered non-profit company since August 2018, the sole shareholder of which is the “Foundation for the Catholic Church Community of St. Peter and Paul Eschweiler”.
